cloprostenol - CISMeF

Preferred Label : cloprostenol;

MeSH definition : A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle.;

CISMeF synonym : 55028-72-3 (Cloprostenol sodium);

MeSH hyponym : oestrophan; ICI-80,966; estrumate; Cloprostenol Sodium; ICI 80,966; ICI80,966; Sodium, Cloprostenol; Cloprostenol Monosodium Salt; Monosodium Salt, Cloprostenol; Salt, Cloprostenol Monosodium;

MeSH CAS label : 5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-( -)-;

MeSH Related Number : cloprostenol sodium; 40665-92-7 (Cloprostenol); 55028-72-3 (mono-Na salt); 886SAV9675;

Registry Number MeSH : 40665-92-7;

Related CAS MeSH : 886SAV9675 (Cloprostenol sodium);

Codes EINECS : 255-028-8;

Is substance : O;

UNII : 4208238832;

InChIKey : VJGGHXVGBSZVMZ-QIZQQNKQSA-N;

Details

Origin ID

D003008;

UMLS CUI

C0009030;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cloprostenol sodium (substance) [SNOMED CT concept]
- cloprostenol sodium [SNOMED Notion]
CISMeF manual mappings
- cloprostenol [Substance BNPC]
Currated CISMeF NLP mapping
- Cloprostenol [NCIt concept]
- Cloprostenol (substance) [SNOMED CT concept]
Pharmacological action(s)
- luteolytic agents [MeSH Descriptor]
Record concept(s)
- Cloprostenol Sodium [MeSH concept]
- ICI-80,966 [MeSH concept]
- cloprostenol [MeSH concept]
- estrumate [MeSH concept]
- oestrophan [MeSH concept]
Related MeSH Supplementary Concept(s)
- 16-(3-chlorophenoxy)-9,11a,15-trihydroxy-17,18,19,20-tetranor-11a-homo-5,13-prostadienoic acid [MeSH Supplementary Concept]
- dechloro ethylcloprostenolamide [MeSH Supplementary Concept]
- duotrav [MeSH Supplementary Concept]
- ganfort [MeSH Supplementary Concept]
- glystrophan [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cloprostenol [NCIt concept]
- Cloprostenol (substance) [SNOMED CT concept]
- cloprostenol [Substance BNPC]
Validated automatic mappings to BTNT
- Cloprostenol Sodium [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients